Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor.

Thoracic cancer(2022)

引用 3|浏览26
暂无评分
摘要
Immune checkpoint inhibitors (ICIs) have successfully treated a number of different types of cancer, which is of great significance for cancer treatment. With the widespread use of ICIs in clinical practice, the increasing checkpoint inhibitor pneumonia (CIP) will be a challenge to clinicians. To guide the diagnosis and treatment of CIP, we conducted in-depth discussions based on the latest evidence, forming a consensus among Chinese experts on the multidisciplinary management of CIP.
更多
查看译文
关键词
Chinese experts consensus,checkpoint inhibitor pneumonitis,immune checkpoint inhibitor-related adverse effects
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要